Washington University radiologist, Pamela Woodard, MD, presents an overview and update on how cardiac MRI can provide cardiac assessment and management of patients undergoing chemotherapy. The presentation also includes an accurate assessment of baseline and post-chemotherapy left ventricular systolic function (LVEF) and demonstration of baseline and post-chemotherapy myocardial scarring/fibrosis. Lastly, cardiac MRI has the potential to predict myocardial dysfunction by assessment of pre- and post-treatment measurement of longitudinal and circumferential strain, and through assessment of native (non-contrast) and post-contrast T1-mapping and extracellular volume (ECV).
Related Presenters
Professor of Radiology,
Washington University School of Medicine
St. Louis, MO
Pamela K. Woodard, MD, is the Elizabeth E. Mallinckrodt Professor and director of Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine in St. Louis. In 2017, Woodard was named senior vice chair and division ...
Related Videos
